ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 771 filers reported holding ASTRAZENECA PLC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $18,316,753 | -2.7% | 234,860 | -15.4% | 0.34% | -14.2% |
Q1 2024 | $18,816,307 | +2.7% | 277,731 | +2.1% | 0.40% | -7.2% |
Q4 2023 | $18,325,500 | +12.1% | 272,094 | +12.7% | 0.43% | -4.6% |
Q3 2023 | $16,352,047 | -4.1% | 241,466 | +1.3% | 0.45% | -2.6% |
Q2 2023 | $17,059,031 | +5.2% | 238,354 | +2.0% | 0.46% | -12.1% |
Q1 2023 | $16,222,591 | +6.5% | 233,721 | +4.1% | 0.53% | -4.5% |
Q4 2022 | $15,226,833 | +38.8% | 224,585 | +12.3% | 0.55% | +30.0% |
Q3 2022 | $10,967,000 | -14.9% | 199,974 | +2.5% | 0.43% | -9.9% |
Q2 2022 | $12,889,000 | +13.3% | 195,078 | +13.8% | 0.47% | +30.3% |
Q1 2022 | $11,376,000 | +17.0% | 171,488 | +2.7% | 0.36% | +21.8% |
Q4 2021 | $9,726,000 | +1.4% | 166,975 | +4.6% | 0.30% | -8.3% |
Q3 2021 | $9,589,000 | +60.3% | 159,658 | +59.8% | 0.32% | +57.8% |
Q2 2021 | $5,983,000 | +39.1% | 99,881 | +15.5% | 0.21% | +9.0% |
Q1 2021 | $4,301,000 | -44.9% | 86,496 | -44.6% | 0.19% | +3.3% |
Q4 2020 | $7,810,000 | – | 156,220 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |